Urologie Vaterstetten - Dr. med. Block, Vaterstetten

32. Critz FA, Williams WH, Benton JB, Levinson AK, Holladay CT, Holladay DA: Prostate
specific antigen bounce after radioactive seed implantation followed by external beam
radiation for prostate cancer. J Urol 163:1085-1089, 2000
33. D´Amico AV, Whittington R, Malkowicz SB: Clinical utility of th percentage of positive
prostate biospies in defning biochemical outcome after radical prostectomie for patients
with clinically localized prostate cancer. J Clin Oncol 18:1164-1172, 2000
34. D´Amico A, Chang H, Holupka E: Calculated prostate cancer Volume: The optimal
predictor of actual cancer volume and pathologic stage. Urology 153: 1543–1548, 1997
35. D´Amico AV, Whittington R, Malkowicz SB: Biochemical outcome after radical
prostatectomy,external beam radiation therapy,or interstitial radiation therapy for clinically
localized prostate cancer. JAMA 280: 969-974, 1998
36. Dattoli M, Wallner K, True L: Prognostic role of serum prostatic acid phosphatase for 103-
Pd-based radiation for prostatic carcinoma. J Urol 45:853–886, 1999
37. Davis B, Pisansky T, Wilson T, Rothenberg H, Pacelli A, Hillman D, Sargent D, Bostwick D:
The radial distance of extraprostatic extension of prostate carcinoma: implications for
brachytherapy. Cancer 85: 2630–2637, 1999
38. Davis JW, Kuban D, Lynch W, Schellhammer P: Quality of life after treatment for localized
prostate cancer: Differences based on treatment modality. J Urol 166: 947–952, 2001
39. Desai J, Stock R, Stone N, Iannuzzi C, de Wyngaert J: Acute urinary morbidity following I-
125 interstitial implantation of the prostate gland. Radiat Oncol Invest 6: 135-141, 1998
40. Diefenbach M, Dorsey J, Uzzo R, Hanks G, Greenberg R, Horwitz E, Newton F, Enstrom
P: Decision-Making Strategies for patients with localized prostate cancer. Sem Urol Oncol
20: 55 – 62, 2002
41. Di Muzio N, Mangili P, Longobardi B, Nava L, Losa A, Guazoni G, Villa E Optimization of
prostate brachytherapy. Preliminary results Rad Oncol 60:31, 2001
42. Dobelbower RR, Merick HW, Ahuja RK: I-125 interstitial implant precision high-dose
external beam therapy and 5-FU for unresectable adenocarcinoma of pancreas and
extrahepatic biliary tree. Cancer 58: 2185-2195, 1986
43. Duchesne G: Radiation for prostate cancer. Lancet Oncol: 73–81, 2001
44. Egar A, Bostwick D: Prediction of extraprostatic extension of prostate cancer based on
needle biopsy findings: Perineural invasion lacks significance on multivariate analysis. Am
J Surg Pathol 21: 1426–1500, 1997
45. Elfrink R, Kolkman-Deurloo IK, v Kleffens H, Rijndres A, Schaeken B, Aalbers T, Dries W,
Venselaar J: Quality control of brachytherapy equipment in the Netherlands and Belgium:
Current practice and minimum requirements. Rad Oncol 62: 95-102, 2002
46. Epstein J, Pearson J: Contemporary update of prostate cancer staging nomograms (Partin
Tables) for the new millennium. J Urol 58: 843 – 848, 2001
47. Feldman H, Goldstein I, Hatzichristou DG: Impotence and its medical and psychosocial
correlates: Results of the Massachusetts Male aging study. J Urol 151:54-61, 1994
48. Fiveash JB, Hanks G, Roach M: 3D conformal radiation therapy (3DCRT) for high grade
prostate cancer: A multi-institutional review. Int J Radiat Oncol Biol Phys, 47:335–342,
2000
49. Galalae RM, Kovacs G, Schultze J, Loch T, Rzehak P, Wilhelm R, Berterman H,
Buschbeck B, Kohr P, Kimmig B.: Long-term outcome after elective irradiation of the pelvic
82